Hangtaimycin, a Peptide Secondary Metabolite Discovered from Streptomyces Spectabilis CPCC 200148 by Chemical Screening

Total Page:16

File Type:pdf, Size:1020Kb

Hangtaimycin, a Peptide Secondary Metabolite Discovered from Streptomyces Spectabilis CPCC 200148 by Chemical Screening The Journal of Antibiotics (2016) 69, 835–838 & 2016 Japan Antibiotics Research Association All rights reserved 0021-8820/16 www.nature.com/ja NOTE Hangtaimycin, a peptide secondary metabolite discovered from Streptomyces spectabilis CPCC 200148 by chemical screening Lijie Zuo, Bingya Jiang, Zhibo Jiang, Wei Zhao, Shufen Li, Hongyu Liu, Bin Hong, Liyan Yu, Limin Zuo and Linzhuan Wu The Journal of Antibiotics (2016) 69, 835–838; doi:10.1038/ja.2016.29; published online 9 March 2016 Streptomyces spectabilis is well known for the production of the revealed a major peak with UV-visible absorption profile different aminocyclitol antibiotic spectinomycin that is used clinically for from any of the above known secondary metabolites (Supplementary infections caused by Neisseria gonorrhoeae.1,2 Strains of S. spectabilis Figure S3), suggesting that it contained an unidentified secondary were also reported to produce streptovaricin (an ansamycin), metabolite. The hyphenated HRMS of the peak displayed a molecular metacycloprodigiosin (a tri-pyrrole), spectomycin (a tetrahydro- ion m/z 936.45150 ([M+H]+), which established the molecular + anthracene), bafilomycin (a macrolide), desertomycin (a macrolide), formula C50H61N7O11 (calculated at 936.45018 for [M+H] ) for the spectinabilin and SNF4435 (nitrophenyl pyrone), and TDD (trypto- unidentified secondary metabolite, with 24° of unsaturation and an phan–dehydrobutyrine diketopiperazine, a dipeptide).3–9 Therefore, odd number of nitrogen atoms (Supplementary Figure S4). It was S. spectabilis is capable of synthesizing secondary metabolites with believed to be a new compound after a formula search in SciFinder, structure diversity. which resulted in four compounds with their UV-absorption profiles S. spectabilis CPCC 200148 is a soil isolate from Hangzhou of different from the unidentified secondary metabolite. Zhejiang Province, China. It was identified as a producer of The new compound was then purified for structure elucidation. spectinomycin (actinospectacin) and streptovaricins in the year Fresh spores of S. spectabilis CPCC 200148 were inoculated into 350 1979.10,11 In recent times, we made a chemical screening of secondary ISP2 medium plates (Φ 9.0 cm, each containing 25 ml medium). They metabolites from S. spectabilis CPCC 200148, which revealed that it were incubated at 28 °C for 36 h, to develop into even layers of yellow was a talented strain with many secondary metabolites, including mycelial lawn, which produced comparatively high levels of the new metacycloprodigiosin, spectinabilin, SNF4435 and TDD. In particular, compound (Supplementary Figure S5). These agar cultures were cut we identified a new peptide secondary metabolite (designated as into small pieces, pooled and then extracted with an equal volume of hangtaimycin) with unusual structure moieties. Details of the EtOAc for three times. The EtOAc extract was concentrated and dried discovery, purification and structure determination of hangtaimycin (1.34 g) by rotary evaporation at room temperature, re-dissolved in a are presented below. small volume of EtOAc. It was loaded onto preparative silica gel TLC Fresh agar cultures of S. spectabilis CPCC 200148 from ISP2 for fractionation with a more polar mobile phase of EtOAc-n-hexane- medium (yeast extract 0.4%, malt extract 1.0%, glucose 0.4% and CH2Cl2-CH3OH, 5:5:2:2, v/v. The dark band at Rf 0.32 under UV agar 1.5%) plates incubated at 28 °C for 6 days were extracted with 254 nm (corresponding to the above band at Rf 0.21) was scraped off, ethyl acetate (EtOAc). The extract was analyzed by HPLC, TLC and extracted with EtOAc and dried (150 mg). It was re-dissolved in LC-MS. HPLC peaks with UV-visible absorption profiles identical or MeCN and then subjected to semi-preparative reverse-phase HPLC very similar to streptovaricins, prodigiosins, spectinabilin and for final purification. After vacuum evaporation, a white amorphous SNF4435 were found, and MS verified them to be members or powder of the pure new compound (1, 6.0 mg) was obtained. It 20 components of these antibiotics (Supplementary Figures S1 and S2). showed [α] D − 30.4 (c 0.10, MeOH) and UV (MeOH) λmax (log ε): Besides, an HPLC peak with UV absorption profile identical to TDD 219 (5.37), 266 (5.22) nm. was also observed (Supplementary Figure S3). Compound 1 was analyzed by NMR. The 1HNMRspectrumof1 In the silica gel TLC developed with EtOAc-n-hexane-CH2Cl2- showed distinctly 18 olefinic proton signals and 5 amino/amide proton CH3OH, 5:5:2:1, v/v, a dark band at Rf 0.21 under UV 254 nm aroused signals in the lower field region (Supplementary Figure S6). In our attention, as the following HPLC of this band’s EtOAc extract addition, the spectrum displayed seven methyl groups (including Key Laboratory of Biotechnology of Antibiotics of Ministry of Health, Institute of Medicinal Biotechnology, CAMS & PUMC, Beijing, China Correspondence: Professor L Wu or Dr B Jiang, Key Laboratory of Biotechnology of Antibiotics of Ministry of Health, Institute of Medicinal Biotechnology, CAMS & PUMC, Tiantan Xili, Beijing 100050, China. E-mail: [email protected] or [email protected] Received 2 December 2015; revised 30 January 2016; accepted 4 February 2016; published online 9 March 2016 Hangtaimycin from Streptomyces spectabilis LZuoet al 836 one oxygenated methyl group at δ 3.18 and one nitrogenated methyl The connectivity of fragments 1 and 2 via the methylene C-10 was group at δ 2.94), five methylene and six methine proton signals, clearly demonstrated by the HMBC correlations from H-10 to C-2, together with an overlapping singlet attributed to hydroxyl C-3, C-9 and C-16, and from H-11 to C-3 (Figure 1). 1 1 proton signal. The 13C NMR and DEPT spectra of 1 showed 50 The H- HCOSYcorrelationsofH3-22/H-21/H-20/NH-23 and carbon resonances corresponding to the above groups, as well as 15 H-29/H-30/H-31/H-32/H2-33/H2-34/H2-35, and HMBC correlations quaternary carbons (8 amide or ester carbonyls, 7 sp2 carbons) of H-20 to C-19, C-24, H-21 to -OCH3,H2-26 to C-24, NH-27 to (Supplementary Figures S7 and S8). C-24, C-26 and C-28, H-29 and H-30 to C-28 revealed the presence of The proton and hydrogen-bearing carbon resonances in the fragment 3 that contained a 3-O-methyl-threonine, a dehydroalanine 1 NMR spectra of 1 were assigned unambiguously by HSQC and a conjugated octanoic acid in (Figure 1). 1 1 spectroscopic data interpretation (Table 1 and Supplementary The H- H COSY correlations of H-52/H-53/H-54/H-55/H3-56 and H -37/H-38/H-42/NH-43, and HMBC correlations from H-52, H-53 Figure S9). 2 to C-51, H -46 to C-44, C-45 and C-47, H-47 to C-44, C-46, and In the 1H-1H gCOSY spectrum of 1 (Supplementary Figure S10), 3 H-43, H-46 and H-47 to C-44 demonstrated the presence of fragment the homonuclear coupling correlations NH-1/H-2, H-4/H-5/H-6/H-7 4 consisted of 1-amino-1-propanol, 2-methyl-2-ene-4-amino-penta- revealed the presence of structural units containing the vicinal 1 1 noic acid and 2,4-hexadienoic acid in (Figure 1). coupled protons (Figure 1, thick lines). In the HMBC spectrum of The linkage of fragments 3 and 4 by a δ-valerolactone ring was (Supplementary Figure S11), the following cross-peaks were observed: clearly demonstrated by the HMBC correlations from H-34, H-35, NH-1, H-2/C-3, C-8 and C-9; H-4, H-6/C-9; H-5/C-8, C-9; H-7/C-3, H-37 and H-38 to C-36, H-35, H-37 to C-41 and H-41 to C-40 C-8. These correlations, in combination with the shifts of these (Figure 1). proton and carbon resonances, demonstrated the presence of a C-3- The association of C-19 and the diketopiperazine moiety via a substituted indolyl moiety in 1 (Figure 1, fragment 1). nitrogen atom (N-15) was suggested by the chemical shift of C-19 1 1 The H- H gCOSY correlations (H-10/H-11 and H-17/H3-18) and (δ 167.0), the accurate assignment five out of the six exchangeable HMBC correlations (H3-18, H-17/C-13, C-14; H-11/C-13, C-16 and proton signals, together with 1’s molecular formula C50H61N7O11 with N-CH3; N-CH3/C-13, C-14), together with the chemical shift values of 24° of unsaturation. these carbons, indicated the presence of a cyclodipeptide moiety The geometrical configurations of four double bonds in compound (N-methylalanine-dehydrobutyrine; Figure 1, fragment 2) in 1. 1 were determined to be 29Z,31E,52Z and 54E by coupling constants Table 1 The NMR spectra data of hangtaimycin (compound 1) in DMSO-d6 Position δC δH (J in Hz) Position δC δH (J in Hz) 1 — 10.93 br. s 29 123.1 6.26 d (10.2) 2 125.3 6.94 d (2.4) 30 140.9 7.09 dd (15.0, 10.2) 3 107.3 31 129.0 6.22 (overlap) 4 111.1 7.29 d (8.4) 32 142.2 6.20 dt (15.0, 6.6) 5 121.0 7.02 t (7.2) 33 31.7 2.18 q (7.2) 6 118.6 6.92 t (7.2) 34 25.1 1.62 m 7 118.0 7.32 d (8.4) 35 35.3 2.29 t (7.2) 8 136.2 36 163.7 9 127.0 37 28.6 2.48 (overlap) 10 26.3 3.24 dd (14.4, 4.8) 38 77.2 4.37 m 3.35 dd (14.4, 4.2) 40 161.6 11 64.6 4.70 dd (4.8, 4.2) 41 114.6 5.74 s N-CH3 31.4 2.94 s 42 73.3 5.36 dd (13.2, 7.2) 13 162.3 42-OH 6.25 br.
Recommended publications
  • Production of Plant-Associated Volatiles by Select Model and Industrially Important Streptomyces Spp
    microorganisms Article Production of Plant-Associated Volatiles by Select Model and Industrially Important Streptomyces spp. 1, 2, 3 1 Zhenlong Cheng y, Sean McCann y, Nicoletta Faraone , Jody-Ann Clarke , E. Abbie Hudson 2, Kevin Cloonan 2, N. Kirk Hillier 2,* and Kapil Tahlan 1,* 1 Department of Biology, Memorial University of Newfoundland, St. John’s, NL A1B 3X9, Canada; [email protected] (Z.C.); [email protected] (J.-A.C.) 2 Department of Biology, Acadia University, Wolfville, NS B4P 2R6, Canada; [email protected] (S.M.); [email protected] (E.A.H.); [email protected] (K.C.) 3 Department of Chemistry, Acadia University, Wolfville, NS B4P 2R6, Canada; [email protected] * Correspondence: [email protected] (N.K.H.); [email protected] (K.T.) These authors contributed equally. y Received: 13 October 2020; Accepted: 9 November 2020; Published: 11 November 2020 Abstract: The Streptomyces produce a great diversity of specialized metabolites, including highly volatile compounds with potential biological activities. Volatile organic compounds (VOCs) produced by nine Streptomyces spp., some of which are of industrial importance, were collected and identified using gas chromatography–mass spectrometry (GC-MS). Biosynthetic gene clusters (BGCs) present in the genomes of the respective Streptomyces spp. were also predicted to match them with the VOCs detected. Overall, 33 specific VOCs were identified, of which the production of 16 has not been previously reported in the Streptomyces. Among chemical classes, the most abundant VOCs were terpenes, which is consistent with predicted biosynthetic capabilities. In addition, 27 of the identified VOCs were plant-associated, demonstrating that some Streptomyces spp.
    [Show full text]
  • Ep 2434019 A1
    (19) & (11) EP 2 434 019 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 28.03.2012 Bulletin 2012/13 C12N 15/82 (2006.01) C07K 14/395 (2006.01) C12N 5/10 (2006.01) G01N 33/50 (2006.01) (2006.01) (2006.01) (21) Application number: 11160902.0 C07K 16/14 A01H 5/00 C07K 14/39 (2006.01) (22) Date of filing: 21.07.2004 (84) Designated Contracting States: • Kamlage, Beate AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 12161, Berlin (DE) HU IE IT LI LU MC NL PL PT RO SE SI SK TR • Taman-Chardonnens, Agnes A. 1611, DS Bovenkarspel (NL) (30) Priority: 01.08.2003 EP 03016672 • Shirley, Amber 15.04.2004 PCT/US2004/011887 Durham, NC 27703 (US) • Wang, Xi-Qing (62) Document number(s) of the earlier application(s) in Chapel Hill, NC 27516 (US) accordance with Art. 76 EPC: • Sarria-Millan, Rodrigo 04741185.5 / 1 654 368 West Lafayette, IN 47906 (US) • McKersie, Bryan D (27) Previously filed application: Cary, NC 27519 (US) 21.07.2004 PCT/EP2004/008136 • Chen, Ruoying Duluth, GA 30096 (US) (71) Applicant: BASF Plant Science GmbH 67056 Ludwigshafen (DE) (74) Representative: Heistracher, Elisabeth BASF SE (72) Inventors: Global Intellectual Property • Plesch, Gunnar GVX - C 6 14482, Potsdam (DE) Carl-Bosch-Strasse 38 • Puzio, Piotr 67056 Ludwigshafen (DE) 9030, Mariakerke (Gent) (BE) • Blau, Astrid Remarks: 14532, Stahnsdorf (DE) This application was filed on 01-04-2011 as a • Looser, Ralf divisional application to the application mentioned 13158, Berlin (DE) under INID code 62.
    [Show full text]
  • Genomic and Phylogenomic Insights Into the Family Streptomycetaceae Lead to Proposal of Charcoactinosporaceae Fam. Nov. and 8 No
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.08.193797; this version posted July 8, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Genomic and phylogenomic insights into the family Streptomycetaceae 2 lead to proposal of Charcoactinosporaceae fam. nov. and 8 novel genera 3 with emended descriptions of Streptomyces calvus 4 Munusamy Madhaiyan1, †, * Venkatakrishnan Sivaraj Saravanan2, † Wah-Seng See-Too3, † 5 1Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, 6 Singapore 117604; 2Department of Microbiology, Indira Gandhi College of Arts and Science, 7 Kathirkamam 605009, Pondicherry, India; 3Division of Genetics and Molecular Biology, 8 Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, 9 Malaysia 10 *Corresponding author: Temasek Life Sciences Laboratory, 1 Research Link, National 11 University of Singapore, Singapore 117604; E-mail: [email protected] 12 †All these authors have contributed equally to this work 13 Abstract 14 Streptomycetaceae is one of the oldest families within phylum Actinobacteria and it is large and 15 diverse in terms of number of described taxa. The members of the family are known for their 16 ability to produce medically important secondary metabolites and antibiotics. In this study, 17 strains showing low 16S rRNA gene similarity (<97.3 %) with other members of 18 Streptomycetaceae were identified and subjected to phylogenomic analysis using 33 orthologous 19 gene clusters (OGC) for accurate taxonomic reassignment resulted in identification of eight 20 distinct and deeply branching clades, further average amino acid identity (AAI) analysis showed 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.08.193797; this version posted July 8, 2020.
    [Show full text]
  • Front Matter
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY VOLUME 1 * NUMBER 6 * JUNE 1972 EDITORIAL BOARD GLADYS L. HOBBY, Editor-in-Chief (1975) Infectious Disease Research Institute, East Orange, N.J. WALTER D. CELMER, Editor (1975) EDWARD W. HOOK, Editor (1976) Pfizer hIc., Grotoln, Coiml. University of Virginia, Charlottesville JOEL G. FLAKS, Editor (1976) LEON H. SCHMIDT, Editor (1974) University ofPennsylvania, Phliladelphia Southern Research Institute, Birminglham, Ala. Fred Allison, Jr. (1973) H. Grisebach (1974) T. J. Perun (1974) Theodore Anderson (1973) Jack Gwaltney (1974) K. E. Price (1973) Robert Austrian (1974) Fred Hahn (1973) C. Reilly (1972) John Bennett (1973) William Hewitt (1974) R. W. Rickards (1974) Joe Bertino (1974) Richard Hornick (1974) R. W. Riddell (1974) E. Borowski (1973) Milton Huppert (1974) Richard Roberts (1973) D. Buyske (1974) George Gee Jackson (1974) L. Sabath (1973) Yves Chabbert (1974) Keith Jensen (1974) Arthur K. Saz (1973) Patricia Charache (1974) E. H. Kass (1973) F. C. Sciavolino (1973) Ernest Chick (1973) Donald Kaye (1973) Piero Sensi (1974) Leighton E. Cluff (1974) WVm. Kirby (1973) David Smith (1974) Frank Collins (1973) Vernon Knight (1974) Earle Spaulding (1974) John Corcoran (1974) M. Glenn Koenig (1973) Gene Stollerman (1974) Julian Davies (1973) Calvin Kunin (1972) R. Sutherland (1973) Bernard Davis (1973) Mark Lepper (1972) Morton N. Swartz (1973) Arnold L. Demain (1973) Robert G. Loudon (1974) Ralph Tompsett (1973) Roger DesPrez (1973) Thomas H. Maran (1974) John P. Utz (1973) Liebor Ebringer (1974) Lester Mitscher (1974) D. Vazquez (1974) H. L. Ennis (1974) S. Mitsuhashi (1974) G. H. Wagman (1974) Maxwell Finland (1973) R. B. Morin (1973) Kenneth S.
    [Show full text]
  • Characterization of Impurities in Commercial Spectinomycin by Liquid Chromatography with Electrospray Ionization Tandem Mass Spectrometry
    The Journal of Antibiotics (2014) 67, 511–518 & 2014 Japan Antibiotics Research Association All rights reserved 0021-8820/14 www.nature.com/ja ORIGINAL ARTICLE Characterization of impurities in commercial spectinomycin by liquid chromatography with electrospray ionization tandem mass spectrometry Yan Wang, Mingjuan Wang, Jin Li, Shangchen Yao, Jing Xue, Wenbo Zou and Changqin Hu Analysis of commercial spectinomycin samples with ion-pairing reversed-phase LC coupled with electrospray ionization tandem MS (LC/ESI-MS/MS) indicates that eight additional compounds are present, including actinamine, (4R)-dihydrospectinomycin, (4S)-dihydrospectinomycin and dihydroxyspectinomycin, as well as four new impurities reported, to our knowledge, for the first time. The structures of these compounds were elucidated by comparing their fragmentation patterns with known structures, and NMR was employed to characterize and distinguish (4R)-dihydrospectinomycin and (4S)-dihydrospectinomycin. Identification of dihydrospectinomycin isomers is necessary because (4R)-dihydrospectinomycin is a minor active pharmaceutical ingredient of spectinomycin, whereas (4S)-dihydrospectinomycin is considered to be an impurity (impurity C) by the European Pharmacopoeia (Ph. Eur.). The Journal of Antibiotics (2014) 67, 511–518; doi:10.1038/ja.2014.32; published online 16 April 2014 Keywords: (4R)-dihydrospectinomycin; (4S)-dihydrospectinomycin; liquid chromatography with tandem MS; spectinomycin; structural characterization INTRODUCTION electrochemical detection that has no volatile
    [Show full text]
  • Tackling Antibiotic Resistance with Compounds of Natural Origin: a Comprehensive Review
    biomedicines Review Tackling Antibiotic Resistance with Compounds of Natural Origin: A Comprehensive Review Francisco Javier Álvarez-Martínez 1 , Enrique Barrajón-Catalán 1,* and Vicente Micol 1,2 1 Institute of Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universitas Miguel Hernández (UMH), 03202 Elche, Spain; [email protected] (F.J.Á.-M.); [email protected] (V.M.) 2 CIBER, Fisiopatología de la Obesidad y la Nutrición, CIBERobn, Instituto de Salud Carlos III (CB12/03/30038), 28220 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-965222586 Received: 18 September 2020; Accepted: 9 October 2020; Published: 11 October 2020 Abstract: Drug-resistant bacteria pose a serious threat to human health worldwide. Current antibiotics are losing efficacy and new antimicrobial agents are urgently needed. Living organisms are an invaluable source of antimicrobial compounds. The antimicrobial activity of the most representative natural products of animal, bacterial, fungal and plant origin are reviewed in this paper. Their activity against drug-resistant bacteria, their mechanisms of action, the possible development of resistance against them, their role in current medicine and their future perspectives are discussed. Electronic databases such as PubMed, Scopus and ScienceDirect were used to search scientific contributions until September 2020, using relevant keywords. Natural compounds of heterogeneous origins have been shown to possess antimicrobial capabilities, including against antibiotic-resistant bacteria. The most commonly found mechanisms of antimicrobial action are related to protein biosynthesis and alteration of cell walls and membranes. Various natural compounds, especially phytochemicals, have shown synergistic capacity with antibiotics. There is little literature on the development of specific resistance mechanisms against natural antimicrobial compounds.
    [Show full text]
  • 16S Ribosomal Methylation: Emerging Aminoglycoside Resistance
    Yohei Doi, MD, PhD Division of Infectious Diseases University of Pittsburgh School of Medicine Background on aminoglycosides Resistance mechanisms New aminoglycosides Streptomycin, produced by a species of Streptomyces, was the first aminoglycoside discovered All subsequent aminoglycosides were derived from Streptomyces spp. (-mycin) or from Micromonospora spp. (-micin) Active against various groups of bacteria . Not active against anaerobes Mandell: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed. Amino-glycoside amino-containing or non- amino-containing sugars six-membered ring with amino group substituents = aminocyclitol kanamycin Generic Name Source Year Reported Streptomycin Streptomyces griseus 1944 Neomycin Streptomyces fradiae 1949 Kanamycin Streptomyces kanamyceticus 1957 Paromomycin Streptomyces fradiae 1959 Gentamicin Micromonospora purpurea and Micromonospora echinospora 1963 Tobramycin Streptomyces tenebrarius 1967 Amikacin Streptomyces kanamyceticus 1972 Netilmicin Micromonospora inyoensis 1975 Spectinomycin Streptomyces spectabilis 1961 Sisomicin Micromonospora inyoensis 1970 Dibekacin Streptomyces kanamyceticus 1971 Isepamicin Micromonospora purpurea 1978 Mandell: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed. Aminoglycosides are used for treatment of various conditions: . Streptomycin – tuberculosis . Paromomycin – cryptosporidiosis, amoebiasis, leishmaniasis . Spectinomycin – gonorrhea . Gentamicin/streptomycin – synergy with β-lactams
    [Show full text]
  • Functional Analysis of Spectinomycin Biosynthetic Genes from Streptomyces Spectabilis ATCC 27741
    J. Microbiol. Biotechnol. (2003), 13(6), 906–911 Functional Analysis of Spectinomycin Biosynthetic Genes from Streptomyces spectabilis ATCC 27741 JO, YOU-YOUNG1, SUN-HEE KIM1, YOUNG-YELL YANG1, CHOONG-MIN KANG2, 3 1 JAE-KYUNG SOHNG , AND JOO-WON SUH 1Department of Biological Science, Institute of Bioscience and Biotechnology, Myong Ji University, Yongin 449-728, Korea 2Childrens Hospital, Harvard Medical School, Boston, MA 02467, U.S.A. 3Department of Chemistry, SunMoon University, Asansi, Chungnam 337-840, Korea Received: May 23, 2003 Accepted: July 15, 2003 Abstract The function of genes related to spectinomycin Spectinomycin is an aminoglycoside antibiotic produced biosynthesis (spcD, speA, speB, spcS2) from Streptomyces by several Streptomyces species such as Streptomyces spectabilis ATCC 27741, a spectinomycin producer, was analyzed. flavopersicus [17], Streptomyces hygroscopicus [31], and Each gene was subcloned from a spectinomycin biosynthetic Streptomyces spectabilis [15]. The antibiotic has a unique gene cluster and overexpressed in E. coli BL21 (DE3) using tricyclic structure in which a single sugar component, pET vector. After incubating each purified protein with its actinospectose, is linked to the diaminocyclitol moiety possible substrates, the final products were analyzed using (actinamine) by β-glycosidic and hemiketal bonds [4, 30]. high-performance liquid chromatography (HPLC). From these It blocks the translocation step of protein synthesis by results, spcD, speA, and speB have been identified to be inhibiting the binding of the elongation factor G to the dTDP-glucose synthase, myo-inositol monophosphatase, and ribosome [3]. It possesses a broad spectrum of activities myo-inositol dehydrogenase, respectively. In addition, the against many Gram-positive as well as Gram-negative results suggest that the spcS2 gene product functions downstream bacteria [29].
    [Show full text]
  • Streptomyces Secondary Metabolites
    Chapter 6 Streptomyces Secondary Metabolites MohammedMohammed Harir, Harir, Hamdi Bendif,Hamdi Bendif, Miloud Bellahcene, Zohra Fortas Miloud Bellahcene, Zohra Fortas and Rebecca Pogni and Rebecca Pogni Additional information is available at the end of the chapter Additional information is available at the end of the chapter http://dx.doi.org/10.5772/intechopen.79890 Abstract Actinobacteria are found spread widely in nature and particular attention is given to their role in the production of various bioactive secondary metabolites. Tests on soil samples show that there can be a diversity of actinomycetes depending on the climate, the area it is growing in, how dry the soil is, and the quality of the soil. However, it was agreed after tests in Yunnan, China, that the genus Streptomyces sp. is most important in ecological function, representing up to 90% of all soil actinomycetes, and therefore helping to show the important characteristics needed of the soil actinomycete population. Streptomycete compounds are used for other biological activities, not just for antibiotics. It has been found that metabolites can be broadly divided into four classes: (1) regulatory activi- ties in compounds, these include consideration of growth factors, morphogenic agents and siderophores, and plants promoting rhizobia; (2) antagonistic agents, these include antiprotozoans, antibacterials, antifungals, as well as antivirals; (3) agrobiologicals, these include insecticides, pesticides, and herbicides; and (4) pharmacological agents, these include neurological agents, immunomodulators, antitumorals, and enzyme inhibitors. It is found that Streptomyces hygroscopicus is one of the very best examples because it secretes in excess of 180 secondary metabolites to locate simultaneous bioactivities for a given compound.
    [Show full text]
  • Aminoglycoside Antibiotic-Inactivating Enzymes in Actinomycetes Similar
    Proc. Nat. Acad. Sci. USA Vol. 70, No. 8, pp. 2276-2280, August 1973 Aminoglycoside Antibiotic-Inactivating Enzymes in Actinomycetes Similar to Those Present in Clinical Isolates of Antibiotic-Resistant Bacteria (streptomyces/origin of R-factors/gentamicin-acetate) RAOUL BENVENISTE* AND JULIAN DAVIESt Department of Biochemistry, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, Wis. 53706 Communicated by Henry Lardy, May 11, 1973 ABSTRACT Various species of Streptomyces possess their cellular dimensions, their cytology, and their genetics aminoglycoside-modifying enzymes. Streptomyces kana- place them among the bacteria (5, 6). One of the most striking myceticus contains an enzyme that acetylates the 6'-amino the extent to which they group of kanamycin A and B, gentamicin Cla, and neo- properties of the actinomycetes is mycin. Streptomyces spectabilis produces an enzyme that produce antibiotics; most of the aminoglycoside antibiotics acetylates the 2'-amino group of the hexose ring of genta- (streptomycin, neomycin, kanamycin, gentamicin, tobra- micin Cia. These enzymes catalyze reactions identical to mycin, and lividomycin) are produced by them. those catalyzed by enzymes found in gram-negative bac- Enzymes that modify other antibiotics have been isolated teria containing R(antibiotic resistance)-factors. The dis- covery of these enzymes suggests the possibility of an from Streptomyces species; in studies on the biosynthesis of evolutionary relationship between the aminoglycoside- streptomycin in Streptomyces bikiniensis, Miller and Walker inactivating enzymes (produced by resistance determi- (3, 8) and Nimi and coworkers (9, 10) found three enzymes nants) in bacteria containing R-factors and similar en- that phosphorylated streptomycin. In addition, Argoudelis zymes found in the actinomycetes.
    [Show full text]
  • Spectinomycin Sulfate PRODUCT DATA SHEET Issue Date 01/06/2020
    Spectinomycin sulfate PRODUCT DATA SHEET issue date 01/06/2020 Product Name: Spectinomycin sulfate Product Number: S016 CAS Number: 64058-48-6 Molecular Formula: C14H26N2O11S•H2SO4•4H2O Molecular Weight: 502.49 Form: Powder Appearance: White or almost white powder Source: Streptomyces sp. Water Content (Karl 12.0 - 16.5% Fischer): pH: 3.8 - 5.6 Optical Rotation: +10.0° to +14.0° Storage Conditions: 2 ­ 8°C Description: Spectinomycin Sulfate is an aminocyclitol antibiotic that is isolated from Streptomyces spectabilis. Spectinomycin was discovered in culture broth by researchers at the Upjohn Company in 1961. Spectinomycin Sulfate shows activity against gram-positive bacteria, gram-negative bacteria, and Mycoplasma. Spectinomycin Sulfate is a protein synthesis inhibitor. It acts by inhibiting protein synthesis and elongation by binding to the bacterial 30S ribosomal subunit and interfering with peptidyl tRNA translocation. This eventually leads to bacterial cell death. Spectinomycin is commonly used as a selective agent to isolate cells that contain aadA spectinomycin resistance genes. It also has various uses in plant biology applications. TOKU-E offers two forms of spectinomycin: spectinomycin DiHCl (S006) and Spectinomycin sulfate (S016). In aqueous solution, spectinomycin DiHCl is freely soluble, and spectinomycin sulfate is sparingly soluble (0.150 mg/mL). Synonyms: Togamycin, Trobicin, Spectam, Actinospectacin, U-18409E Mechanism of Action: The aminocyclitol antibiotic spectinomycin, often considered alongside the aminoglycosides, binds in reversible fashion (hence the bacteriostatic activity) to the 16S rRNA of the ribosomal 30S subunit. There it interrupts the translocation event that occurs as the next codon of mRNA is aligned with the A site in readiness for the incoming aminoacyl-tRNA.
    [Show full text]
  • Resistance Factor-Mediated Spectinomycin Resistance
    INFECTION AND IMMUNITY, Jan. 1970, p. 120-127 Vol. 1, No. 1 Copyright ( 1970 American Society for Microbiology Priinted inz U.S.A. Resistance Factor-Mediated Spectinomycin Resistance DAVID H. SMITH, J. A. JANJIGIAN, NAOMI PRESCOTT, AND PORTER W. ANDERSON Department ofPediatrics, Harvard Medical School anid Chlildreni's Hospital Medical Cenlter, Boston, Massachusetts 02115 Received for publication 22 September 1969 Of 100 natural isolates of drug-resistant enteric bacteria, 51 were resistant to spec- tinomycin (Spc) and 46 contained transferable R factors mediating Spc resistance. All SpcR R factors mediated streptomycin and bluensomycin resistance and were fi+ type. Extracts of R-SpcR strains adenylated Spc, dihydrospectinomycin, actinamine streptomycin, and bluensomycin in vitro in the presence of adenosine triphosphate and Mg++. Results of genetic and biochemical studies support the hypothesis that these reactions are mediated by a single enzyme. Spectinomycin (Spc), a dibasic aminoglycoside and the Massachusetts General Hospital were the antibiotic produced by Streptomyces spectabilis, is source of most of the R factors studied. RE130 bacteriostatic for a wide variety of clinically (fi+ SpcR StrR BluR ChlR TetR MerR SulR; 11), important bacteria (16). Spc selectively inhibits the R factor studied in many of the experiments, was in and carried originally by a strain of E. coli. Bacteria used protein synthesis Escherichia coli, strains as to a chromosomal recipients for the R factors included E. coli B resistant to Spc owing muta- and E. coli K-12 strains AB1932-1 (Arg- Met- Lac- tion have 30S ribosomal subunits that are re- NalR; 27) and FW 13A (Thr- Leu- Met- StrR, 19).
    [Show full text]